Your browser doesn't support javascript.
loading
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019.
Kissling, Esther; Rose, Angela; Emborg, Hanne-Dorthe; Gherasim, Alin; Pebody, Richard; Pozo, Francisco; Trebbien, Ramona; Mazagatos, Clara; Whitaker, Heather; Valenciano, Marta.
Afiliação
  • Kissling E; EpiConcept, Paris, France.
  • Rose A; These authors contributed equally to the study and manuscript writing.
  • Emborg HD; EpiConcept, Paris, France.
  • Gherasim A; These authors contributed equally to the study and manuscript writing.
  • Pebody R; Department of Infectious Disease Epidemiology and Prevention, Statens Serum Institut, Copenhagen, Denmark.
  • Pozo F; National Epidemiology Centre, Institute of Health Carlos III, Madrid, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
  • Trebbien R; Public Health England, London, United Kingdom.
  • Mazagatos C; National Centre for Microbiology, National Influenza Reference Laboratory, WHO-National Influenza Centre, Institute of Health Carlos III, Madrid, Spain.
  • Whitaker H; Department of Virus and Microbiological Special diagnostics, National Influenza Center, Statens Serum Institut, Copenhagen, Denmark.
  • Valenciano M; National Epidemiology Centre, Institute of Health Carlos III, Madrid, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Institute of Health Carlos III, Madrid, Spain.
Euro Surveill ; 24(8)2019 Feb.
Article em En | MEDLINE | ID: mdl-30808440
ABSTRACT
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018-January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32-43% against influenza A; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34-38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza B / Vacinas contra Influenza / Avaliação de Resultados em Cuidados de Saúde / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Vírus da Influenza A Subtipo H3N2 / Potência de Vacina Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vírus da Influenza B / Vacinas contra Influenza / Avaliação de Resultados em Cuidados de Saúde / Influenza Humana / Vírus da Influenza A Subtipo H1N1 / Vírus da Influenza A Subtipo H3N2 / Potência de Vacina Tipo de estudo: Diagnostic_studies / Observational_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2019 Tipo de documento: Article